The abstract is read at the publisher; the summary is JClub's.
Human induced pluripotent stem cell–derived microengineered heart tissues expressing CRYAB-R120G at near-endogenous levels show contractile deficits linked to impaired calcium handling.
- Why it matters: Desmin-related cardiomyopathy from CRYAB mutations lacks a genetically matched preclinical model, limiting evaluation of mechanisms and therapies under physiologic expression.
- What they did: The team engineered human iPSCs to express CRYAB-R120G and tested maturation conditions, finding 3D mechanical loading is essential for Desmin expression and aggregation. They then measured calcium handling and contractility in microengineered heart tissues and tested itacitinib, a Janus kinase 1 inhibitor.
- The result: Contractile deficits are associated with impaired calcium handling, consistent with electromechanical uncoupling, and itacitinib partially rescued contractility, supporting this therapeutic approach in the human model.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.